Literature DB >> 15026053

Complestatin synthetic studies; the effect of the amino acid configuration on peptide backbone conformation in the common western BCD macrocycle.

Amos B Smith1, Jason J Chruma, Qiang Han, Joseph Barbosa.   

Abstract

The synthesis and structural analysis, involving X-ray crystallographic, nuclear magnetic resonance, and computational studies of four diastereomers of the common western BCD diarylether macrocycle of the complestatins, a family of HIV entry inhibitors, has been achieved exploiting a ruthenium-promoted intramolecular S(N)Ar reaction. The stereogenicity of the individual phenylglycines (residues C and D) results in remarkable effects on the backbone conformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026053     DOI: 10.1016/j.bmcl.2004.01.056

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  A Pd(0)-mediated indole (macro)cyclization reaction.

Authors:  Steven P Breazzano; Yam B Poudel; Dale L Boger
Journal:  J Am Chem Soc       Date:  2013-01-17       Impact factor: 15.419

2.  Total synthesis of complestatin: development of a Pd(0)-mediated indole annulation for macrocyclization.

Authors:  Hiroyuki Shimamura; Steven P Breazzano; Joie Garfunkle; F Scott Kimball; John D Trzupek; Dale L Boger
Journal:  J Am Chem Soc       Date:  2010-06-09       Impact factor: 15.419

3.  Synthesis and stereochemical determination of complestatin A and B (neuroprotectin A and B).

Authors:  Steven P Breazzano; Dale L Boger
Journal:  J Am Chem Soc       Date:  2011-10-20       Impact factor: 15.419

4.  Total synthesis of chloropeptin II (complestatin) and chloropeptin I.

Authors:  Joie Garfunkle; F Scott Kimball; John D Trzupek; Shinobu Takizawa; Hiroyuki Shimamura; Masaki Tomishima; Dale L Boger
Journal:  J Am Chem Soc       Date:  2009-11-11       Impact factor: 15.419

5.  Polycyclic peptide and glycopeptide antibiotics and their derivatives as inhibitors of HIV entry.

Authors:  Maria N Preobrazhenskaya; Eugenia N Olsufyeva
Journal:  Antiviral Res       Date:  2006-05-06       Impact factor: 5.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.